Arcellx, Inc. (ACLX)
NASDAQ·Healthcare·Biotechnology
$115.10
+0.06%
Mkt Cap $6.73B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $12.56M | $4.40M | -64.97% | -$1.01 | -$1.01 | +0.00% | — | — |
| Q4 2025 Nov 5, 2025 | $12.64M | $4.95M | -60.85% | -$0.96 | -$0.99 | -3.13% | — | — |
| Q3 2025 Aug 7, 2025 | $13.71M | $7.55M | -44.90% | -$1.03 | -$0.94 | +8.74% | — | — |
| Q2 2025 May 8, 2025 | $12.87M | $8.13M | -36.84% | -$0.84 | -$1.13 | -34.52% | — | — |
| Q1 2025 Feb 27, 2025 | $25.71M | $15.27M | -40.63% | -$0.63 | -$0.87 | -38.10% | — | — |
| Q4 2024 Nov 7, 2024 | $38.73M | $26.03M | -32.78% | -$0.54 | -$0.48 | +11.11% | — | — |
| Q3 2024 Aug 8, 2024 | $22.04M | $27.38M | +24.27% | -$0.54 | -$0.51 | +5.56% | — | — |
| Q2 2024 May 9, 2024 | $20.67M | $39.26M | +89.96% | -$0.51 | -$0.14 | +72.55% | — | — |
| Q1 2024 Feb 28, 2024 | $20.07M | $63.15M | +214.71% | -$0.61 | $0.42 | +168.85% | — | — |
| Q4 2023 Nov 13, 2023 | $17.49M | $14.96M | -14.50% | -$0.56 | -$0.81 | -44.64% | — | — |
| Q3 2023 Aug 14, 2023 | $39.29M | $14.30M | -63.60% | -$0.68 | -$0.50 | +26.47% | — | — |
| Q2 2023 May 8, 2023 | $100.97M | $17.91M | -82.26% | $2.52 | -$0.58 | -123.02% | — | — |
| Q1 2023 Mar 29, 2023 | $3.00M | — | — | -$0.71 | -$0.76 | -7.04% | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | -$0.93 | -$0.68 | +26.88% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$1.20 | -$0.88 | +26.67% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$0.95 | -$1.56 | -64.21% | — | — |
| Q1 2022 Feb 7, 2022 | — | — | — | -$0.66 | -$0.62 | +6.63% | — | — |
| Q1 2022 Jan 14, 2022 | — | — | — | — | -$0.78 | — | — | — |
| Q2 2021 Jun 30, 2021 | — | — | — | — | -$0.73 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | — | — | — | -$0.52 | — | — | — |